Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: guarantee (67), certify (32), warrant (16)

Docetaxel (30)-Prednisolone ver1.1

Description: Chemotherapy Protocol PROSTATE DOCETAXEL(30)-PREDNISOLONE Regimen Prostate-Docetaxel (30)-Prednisolone Indication Advanced castrate resistant prosta
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-30-Prednisolone-ver1.1.pdf

Darolutamide

Description: Chemotherapy Protocol PROSTATE CANCER DAROLUTAMIDE Regimen • Prostate - Darolutamide Indication • Darolutamide is recommended where the; - patient h
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Darolutamide.pdf

Abiraterone-Prednisolone ver1.1

Description: Chemotherapy Protocol PROSTATE ABIRATERONE-PREDNISOLONE Funding may be required for specific indications Regimen Prostate-Abiraterone-Prednisolone I
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Abiraterone-Prednisolone-ver1.1.pdf

Vinorelbine (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication Second lin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

Everolimus v1.1

Description: Chemotherapy Protocol RENAL CELL EVEROLIMUS This protocol may require funding Regimen Renal Cell - Everolimus Indication Advanced renal cell carcino
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Everolimus-v1.1.pdf

Rituximab (weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (weekly) Regimen Lymphoma – Rituximab (weekly) Indication CD20 positive indolent non Hodgkin’s lymphoma. To
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-weekly.pdf

Rituximab (3 weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (3 Weekly) Regimen Lymphoma – Rituximab (3 weekly) Indication Non Hodgkin’s Lymphoma in combination with ch
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-3-weekly.pdf

Ibrutinib (WM) (420mg)

Description: Chemotherapy Protocol Waldenström's Macroglobulinaemia (WM) Regimen Ibrutinib • WM – Ibrutinib (420mg) Indication • The treatment of adult patients
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-WM-420mg.pdf

Trabectedin v1

Description: Chemotherapy Protocol SARCOMA Regimen TRABECTEDIN Sarcoma-Trabectedin Indication Trabectedin is recommended as a possible treatment for people with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Trabectedin-v1.pdf

Imatinib v1

Description: Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Imatinib Regimen GIST-Imatinib Indication Imatinib is recommended as a possibl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Imatinib-v1.pdf

831 to 840 of 1000

Previous … 82 83 84 85 86 … Next